Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03963739 · ClinicalTrials.gov registry record
Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 255
- Enrollment target
NCT03963739 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 255 participants.
The verdict
NCT03963739 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 255 participants
- Enrollment target
Study Summary
The objective of this study is to examine how adenocarcinoma of the prostate treatment differentially affects African American men's ability to work and to describe and compare changes in work ability (as measured through self-reported global work ability item) reported by African American and white adenocarcinoma of the prostate survivors before treatment and 6 months after treatment completion.
Interventions
- OTHER Questionnaire Administration
- OTHER Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2019-07-19 |
| Est. Completion | 2025-03-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03963739
The ClinicalTrials.gov registry entry for NCT03963739 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 255 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT03963739 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03963739 about?
NCT03963739 is a clinical study titled "Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer". The objective of this study is to examine how adenocarcinoma of the prostate treatment differentially affects African American men's ability to work and to describe and compare changes in work ability (as measured through self-reported global work ability item) reported by African American and white...
What is the current status of trial NCT03963739?
This trial is currently completed. The enrollment target is 255 participants. The study started on 2019-07-19. Estimated completion is 2025-03-25.
What interventions are being tested in trial NCT03963739?
The interventions under investigation include: Questionnaire Administration (OTHER), Interview (OTHER).
Who is sponsoring clinical trial NCT03963739?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.